0 Replies
Stories include:
The FDA has once again postponed the release of its first draft guidance for pharma's use of social media. Report
Dainippon Sumitomo inked a licensing deal that gives Takeda Pharmaceutical exclusive marketing rights to its antipsychotic drug Latuda in most of Europe, the Nikkei business daily reported. Report Contine Reading & Discuss→
0 Replies
Stories include:
With its lead therapy not yet in the clinic, RNAi pioneer RXi has engineered the takeover of Apthera for a chunk of stock and replaced its CEO with one of its board members. And the merger--which buoyed its shares by about 10 percent this morning--immediately puts the expanded... Contine Reading & Discuss→
0 Replies
WORCESTER, Mass., Mar 31, 2011 (BUSINESS WIRE) — RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of... Contine Reading & Discuss→
0 Replies
How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects fo ... Contine Reading & Discuss→
0 Replies
How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects fo ... Contine Reading & Discuss→
0 Replies
On March 16, Novartis said that it will decrease R&D in the U.K. with reports putting the number of jobs to be cut between 400 and 550. This places the pharma giant in the company of GlaxoSmithKline, Merck & Co., Pfizer, and Roche. Over the past two years all have... Contine Reading & Discuss→
0 Replies
Stories include:
@FierceBiotech: Cancer drug developer MethylGene raises $34.5M.
@JohnCFierce: Americans pay $4,000 a month for Gilenya, Germans $2,620. I wonder how much Yervoy will cost in Europe. Article Contine Reading & Discuss→
0 Replies
Stories include:
Novartis expects growth in China to recover after business restructuring in the country slowed the Swiss drug giant's sales there last year, Chief Executive Joe Jimenez said. Report
Pfizer reached a $263 million-plus settlement with asbestos claimants that may bring an end to its Quigley unit's seven-year-old bankruptcy... Contine Reading & Discuss→
